Where Can I Find Ozempic and Mounjaro in Los Cabos?

The journey of GLP-1 receptor agonists began in 2005 with the FDA approval of Exenatide, marketed as Byetta. This groundbreaking medication was originally developed for diabetes management and required twice-daily injections. In 2010, Liraglutide entered the market under the name Victoza, offering a once-daily alternative. It was later repurposed for chronic weight management under the brand Saxenda. The evolution continued with Dulaglutide (Trulicity) in 2014, which reduced the injection frequency to once per week.

A major breakthrough came in 2017 with the approval of Semaglutide, known as Ozempic for diabetes and later rebranded as Wegovy for obesity management in 2021. Most recently, in 2023, Tirzepatide—a dual GLP-1/GIP agonist—was introduced under the names Mounjaro and Zepbound.

With the rising success of these medications, pharmaceutical companies have ramped up research on additional peptides, including Mazdutide, Survodutide, Cagrilintide, and Retatrutide. Retatrutide is currently the frontrunner, nearing the completion of phase 3 clinical trials under Eli Lilly. Though it is already being sold by research peptide companies, the gray market presents significant risks, such as contamination with harmful substances like lipopolysaccharides (LPS). Proper testing is crucial if considering this route—an expensive and uncertain endeavor.

For those seeking treatment in Cabo through a licensed physician, Semaglutide and Tirzepatide are the primary options, with Retatrutide likely on the horizon. But which one is right for you? The choice depends on several factors: the amount of weight you need to lose, your willingness to incorporate strength training and dietary changes, and your financial investment in the treatment.

How Do These Peptides Work?

GLP-1 receptor agonists function by mimicking the hormone glucagon-like peptide-1 (GLP-1), which regulates blood sugar and appetite. These peptides slow gastric emptying, reduce hunger, and improve insulin sensitivity. Tirzepatide, a dual agonist, also activates the glucose-dependent insulinotropic polypeptide (GIP) receptor, which enhances its metabolic benefits.

Semaglutide and Tirzepatide have shown remarkable results in clinical trials, with users experiencing substantial weight loss, improved blood sugar control, and reduced risk of cardiovascular disease. Retatrutide, the latest contender, has demonstrated even greater potential, with some studies indicating up to a 24% reduction in body weight.

Cost and Accessibility

Pricing varies significantly. Semaglutide and Tirzepatide treatments can range from $900 to $1,500 per month, depending on location and insurance coverage. Retatrutide’s future pricing remains uncertain, but given its promising efficacy, demand is expected to be high. For those seeking treatment in Cabo, consultation with a reputable doctor is essential to ensure safe and effective use of these medications.

As research continues, the landscape of weight-loss peptides will keep evolving, offering new and potentially more effective solutions. Whether you're considering Semaglutide, Tirzepatide, or waiting for Retatrutide, informed decision-making is key to achieving sustainable weight loss.

Comparing the Top Weight-Loss Peptides: Semaglutide, Tirzepatide, and Retatrutide

The following statistical comparison evaluates Semaglutide (Ozempic, Wegovy), Tirzepatide (Zepbound, Mounjaro), and Retatrutide (nicknamed “Triple G” due to its action on three receptors). It’s important to note that the muscle loss figures cited come from studies where no additional interventions—such as a high-protein diet or strength training—were implemented. Had these been incorporated, muscle loss could have been significantly reduced.

Comparative Summary of Semaglutide vs Tirzepatide vs Retatrutide

Semaglutide (Wegovy, Ozempic)

Clinical trials showed that participants lost an average of 15% of their body weight over 68 weeks. For a 250-pound person, this equates to a 37.5-pound loss. While impressive, 25-30% of the total weight lost was lean muscle mass, raising concerns about muscle preservation. The term “Ozempic Face” has gained traction due to the potential for noticeable volume loss in the face. However, these results were observed without additional interventions like strength training or increased protein intake, which could have mitigated muscle loss.

Despite this drawback, Semaglutide remains a viable weight-loss aid, particularly for those willing to incorporate healthy lifestyle changes. It is also the most affordable of the three peptides discussed. In Cabo, a compounded form is available for approximately $100 per month at a minimum dose of 0.25mg/week.

Tirzepatide (Zepbound, Mounjaro)

Tirzepatide participants experienced a 22.5% reduction in body weight over 72 weeks, meaning a 250-pound individual would lose 56.25 pounds. Notably, only 15-20% of the total loss was lean mass, demonstrating better muscle preservation than Semaglutide. This advantage is attributed to Tirzepatide’s dual action on GLP-1 and GIP receptors, which aids in fat loss while minimizing muscle degradation.

In Cabo, compounded Tirzepatide is available at approximately $250 per month for a 5mg dose, making it a more expensive but more effective option than Semaglutide.

Retatrutide (No Brand Name, Patent Eli Lilly)

The latest contender, Retatrutide, showed the highest weight loss in the shortest period, with participants losing an average of 24.2% of their body weight over just 48 weeks at the highest dose of 12mg/week. Muscle loss was 21% of total weight lost, the lowest proportion relative to the rapid results. This triple agonist activates GLP-1, GIP, and Glucagon receptors, making it the most advanced peptide currently being tested.

Within the bodybuilding community, Retatrutide has been hailed as a potential game-changer, as it is believed to support simultaneous fat loss and muscle gain when paired with adequate protein intake and structured resistance training. If these claims hold true, Retatrutide may redefine body composition management beyond weight loss alone.

Cost and Future Availability

Retatrutide is not yet commercially available, but demand is expected to be high once it is released. Pricing remains speculative, though it will likely be in the same range or higher than Tirzepatide. For those seeking an effective solution now, Tirzepatide offers the best balance of fat loss and muscle retention, while Semaglutide remains the most affordable option. Retatrutide, if it delivers on its potential, could revolutionize the field of weight management in the near future.

As these treatments evolve, those considering GLP-based weight-loss therapies should stay informed and work with medical professionals to ensure safe and effective use. Keep in mind that very few people you see in the gym are weight lifting correctly or eating diets with the right amount of protein. Retatrutide is definitely the most pricey option of the 3 weight loss peptides. Even at the smallest dose of 4mgs it costs $240 per month from research peptide companies and many bodybuilders are taking up to 12 mgs/week which is $480 per month at retail pricing and you should sacrifice a vial and pay to have it tested which is $300.

In short, if you are just the average person who wants to lose 20 or 30 pounds and you aren’t a bodybuilder, then either Semaglutide or Tirzepatide would probably be the best place to start with some simple exercises like pushups or hill walks and try to prioritize protein and fiber over margaritas and nachos. If you are into bodybuilding, get your hands on some Retatrutide but again, I suggest you have it tested the first time to make sure its pure and free of lipopolysaccharides.  

For more information on where to get safe compounded Tirzepatide and Ozempic in Los Cabos or any other questions you have about my articles feel free to email robynlittlewood@yahoo.com or send a whatsapp to me at  +526242119435